These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 21034969)

  • 1. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces.
    Sonnenberg GF; Fouser LA; Artis D
    Adv Immunol; 2010; 107():1-29. PubMed ID: 21034969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 and IL-23: master regulators of innate and adaptive immunity.
    Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
    Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells.
    Hoeve MA; Savage ND; de Boer T; Langenberg DM; de Waal Malefyt R; Ottenhoff TH; Verreck FA
    Eur J Immunol; 2006 Mar; 36(3):661-70. PubMed ID: 16482511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-22 and inflammation: leukin' through a glass onion.
    Zenewicz LA; Flavell RA
    Eur J Immunol; 2008 Dec; 38(12):3265-8. PubMed ID: 19016525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling.
    Diveu C; Lak-Hal AH; Froger J; Ravon E; Grimaud L; Barbier F; Hermann J; Gascan H; Chevalier S
    Eur Cytokine Netw; 2004; 15(4):291-302. PubMed ID: 15627637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.
    Sonnenberg GF; Fouser LA; Artis D
    Nat Immunol; 2011 May; 12(5):383-90. PubMed ID: 21502992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-21: a new modulator of immunity, infection, and cancer.
    Brandt K; Singh PB; Bulfone-Paus S; Rückert R
    Cytokine Growth Factor Rev; 2007; 18(3-4):223-32. PubMed ID: 17509926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.
    Li J; Tomkinson KN; Tan XY; Wu P; Yan G; Spaulding V; Deng B; Annis-Freeman B; Heveron K; Zollner R; De Zutter G; Wright JF; Crawford TK; Liu W; Jacobs KA; Wolfman NM; Ling V; Pittman DD; Veldman GM; Fouser LA
    Int Immunopharmacol; 2004 May; 4(5):693-708. PubMed ID: 15120653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis.
    Larsen JM; Bonefeld CM; Poulsen SS; Geisler C; Skov L
    J Allergy Clin Immunol; 2009 Feb; 123(2):486-92. PubMed ID: 18986691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 and its activators in intestinal defense and mucosal homeostasis.
    Hruz P; Dann SM; Eckmann L
    Curr Opin Gastroenterol; 2010 Mar; 26(2):109-15. PubMed ID: 20040863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity.
    Puccetti P; Belladonna ML; Grohmann U
    Crit Rev Immunol; 2002; 22(5-6):373-90. PubMed ID: 12803317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-33: a sheep in wolf's clothing?
    Gadina M; Jefferies CA
    Sci STKE; 2007 Jun; 2007(390):pe31. PubMed ID: 17565120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
    Monteleone G; Pallone F; Macdonald TT
    Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting IL-23 in autoimmunity.
    Hölscher C
    Curr Opin Investig Drugs; 2005 May; 6(5):489-95. PubMed ID: 15912962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-23: a promising therapeutic target for systemic lupus erythematosus.
    Leng RX; Pan HF; Chen GM; Wang C; Qin WZ; Chen LL; Tao JH; Ye DQ
    Arch Med Res; 2010 Apr; 41(3):221-5. PubMed ID: 20682181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.
    Wu PW; Li J; Kodangattil SR; Luxenberg DP; Bennett F; Martino M; Collins M; Dunussi-Joannopoulos K; Gill DS; Wolfman NM; Fouser LA
    J Mol Biol; 2008 Oct; 382(5):1168-83. PubMed ID: 18675824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of IL-21 and the IL-21 receptor.
    Mehta DS; Wurster AL; Grusby MJ
    Immunol Rev; 2004 Dec; 202():84-95. PubMed ID: 15546387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.